Abstract:Objective Our objectives were to describe the use of thromboprophylaxis and the incidence of VTE/bleeding in critically ill patients with hematologic malignancies (HM). Design Retrospective cohort study (2014–2022). Setting Medic-Surgical Intensive Care Unit (ICU) in a tertiary care academic center. Patients Adult patients admitted to ICU with a concomitant diagnosis of a hematological malignancy. Interventions None. Main variables of interest We analyzed demographic data, use of thromboprophylaxis and secondary outcomes that included incidence of VTE (venous thromboembolism), bleeding, mortality, severity scores and organ support. We applied a multivariable logistic regression model to examine the risk of thrombosis in the ICU. Results We included 862 ICU admissions (813 unique patients). Thromboprophylaxis was given during 65% of admissions (LMWH 14%, UFH 8%, and SCDs 43%); in 21% it was contraindicated due to thrombocytopenia; 14% of cases lacked documentation on prophylaxis. There were 38 unique incident cases of VTE (27 DVT, 11 PE), constituting 4.4% of ICU episodes. Most of VTE cases happened in patients with various degrees of thrombocytopenia. In the multivariable analysis, SOFA score on the first ICU day was independently associated (OR 0.85, 95% CI 0.76−0.96) with the risk of VTE. Bleeding occurred in 7.2% (minor) and 14.4% (major) of episodes; most frequent sites being CNS, abdomen/GI and pulmonary. Conclusions In this cohort of critically ill patients with HM, there was considerable variability in the utilization of DVT prophylaxis, with predominant use of SCDs. The incidence of VTE was 4.4% and major bleeding 14%. Clinical Trial Registration NCT05396157. Venous Thromboembolism in Hematologic Malignancy and Hematopoietic Cell Transplant Patients: a Retrospective Study ( https://clinicaltrials.gov/ ). Resumen Objetivo Describir el uso de tromboprofilaxis y la incidencia de enfermedad tromboembólica y/o sangrado en pacientes críticos con enfermedad oncohematológica. Diseño Estudio retrospectivo de cohorte (2014–2022). Ámbito Unidad cuidados intensivos medico-quirúrgica de un hospital terciario académico en Toronto, Canadá. Pacientes Adultos con diagnóstico de enfermedad oncohematológica ingresados en la UCI. Intervenciones Ninguna. Variables de interés principales Se analizaron los datos demográficos, el tipo de tromboprofilaxis utilizada y el riesgo de sangrado junto con los factores relacionados con éstos. Se aplicó un análisis de regresión logística multivariante para evaluar factores de riesgo para trombosis en la UCI. Resultados Se incluyeron 862 episodios de ingreso en la UCI (813 pacientes únicos). Se utilizó tromboprofilaxis en el 65% de los casos (heparina de bajo peso molecular 14%, heparina no fraccionada 8% y medios mecánicos 43%); en el 21% estuvo contraindicado por trombocitopenia y en el 14% de los casos no había documentación sobre profilaxis. Hubo 38 casos incidentes de enfermedad trombo embólica venosa o ETEV (27 trombosis venosa profunda, 11 embolismo pulmonar), lo que constituye el 4,4% de los episodios en la UCI. La mayoría de los casos de ETEV ocurrieron en pacientes con diversos grados de trombocitopenia. La puntuación SOFA en el primer día de UCI se relacionó de forma independiente en el análisis multivariable (OR 0.85, 95% CI 0.76−0.96) con el riesgo de ETEV. Se registró sangrado en el 7,2% (menor) y en el 14,4% (mayor) de los episodios; los sitios más frecuentes fueron el SNC, abdomen/GI y pulmonar. Conclusiones En esta cohorte de pacientes críticos con enfermedad oncohematológica, hubo una variabilidad considerable en la utilización de la profilaxis de la TVP, con un uso predominante de métodos mecánicos. La incidencia de ETEV fue del 4,4% y la de hemorragia mayor del 14%.

Severe bleeding events among critically ill patients with haematological malignancies

Hemorrhage and Venous Thromboembolism in Critically Ill Patients with COVID-19

Causes, management, and prognosis of severe gastrointestinal bleedings in critically ill patients with pancreatic cancer: A retrospective multicenter study

Venous thromboembolism in critically ill adult patients with hematologic malignancy: a population-based cohort study

Incidence of venous thromboembolic disease and risk of bleeding in critically ill patients with hematologic malignancies: A retrospective study

Clinical Outcomes and Determinants of Survival in Patients with Hematologic Malignancies Admitted to Intensive Care Units with Critical Illness

Clinical analysis of bleeding and thrombotic events in haematological-oncology patients with severe thrombocytopenia and a high risk of thrombosis

Life‐threatening hemorrhage as defined by the critical administration threshold in nontraumatic critical bleeding: A descriptive observational study

Analysis of Risk Factors and Development of Scoring System to Predict Severity of Upper Gastrointestinal Bleeding in Children

Patient-important upper gastrointestinal bleeding in the ICU: A mixed-methods study of patient and family perspectives

Incidence, Risk Factors and Mortality Associated with Major Bleeding Events in Hospitalized COVID-19 Patients

Management of hematological patients requiring emergency chemotherapy in the intensive care unit

Outcomes of intracranial hemorrhage in critically ill patients with acute leukemia: Results of a retrospective cohort study

Outcomes of non-COVID-19 critically ill patients with hematologic malignancies a 10-year single-center retrospective analysis

Upper Gastrointestinal Hemorrhage In Acute-On-Chronic Liver Failure: Prevalence, Characteristics, And Impact On Prognosis

Impact of critical illness on continuation of anticancer treatment and prognosis of patients with aggressive hematological malignancies

Risk factors for massive gastrointestinal bleeding occurrence and mortality: A prospective single-center study

Hemorrhage under veno-venous extracorporeal membrane oxygenation in acute respiratory distress syndrome patients: a retrospective data analysis

Assessment of bleeding risk in low-weight patients receiving prophylactic subcutaneous unfractionated heparin

Effect of Persistent Thrombocytopenia on Mortality in Surgical Critical Care Patients

Acute respiratory distress syndrome in patients with hematological malignancies: a one-year retrospective nationwide cohort study